# Alejandro (NMI) Hoberman, M.D. – FDA Inspection, Jun 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/alejandro-nmi-hoberman-md/3faa40cc-113f-444b-a217-c2d3476170da
Source feed: FDA_Inspections

> FDA inspection 1241533 of Alejandro (NMI) Hoberman, M.D., June 18, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 50. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241533
- Company Name: Alejandro (NMI) Hoberman, M.D.
- Inspection Date: 2024-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 912599 - 2015-02-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-l-rakestraw/ca138abf-e5d4-43ca-b9d2-79ea6294a8c8)

Company: https://www.keypedia.com/companies/alejandro-nmi-hoberman-md/d78906f3-7db2-4f93-ba44-d21657343105

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
